急性脑梗死动脉溶栓治疗临床疗效观察

打开文本图片集

【摘要】目的：观察对急性脑梗死患者予以动脉溶栓治疗的效果。方法：观察对象选择于2021年12月—2022年12月就诊于我院的87例急性脑梗死患者，随机数字法分组观察，45例予以动脉溶栓治疗者纳入研究组，42例予以静脉溶栓治疗者纳入对照组，对治疗效果进行对比和观察。结果：治疗效果方面，研究组比较对照组更佳（95.56%、73.81%）（P0.05）；与对照组（10.55±1.35）分对比，研究组治疗后NIHSS评分（10.55±1.35）分更佳（P0.05）；与对照组（154.55±11.23）pg/mL、（35.40±5.75）μg/L、（92.35±10.10）μg/L对比，研究组治疗后血清指标（IL-6、TNF-α、CLU）（134.15±11.20）pg/mL、（24.02±5.55）μg/L、（81.12±10.25）μg/L明显较佳（P

【关键词】动脉溶栓治疗；急性脑梗死；神经功能缺损；血清指标

Clinical observation of arterial thrombolysis for acute cerebral infarction

MENG Pengfei

Wuwei People’s Hospital of Gansu Province， Wuwei， Gansu 733000， China

【Abstract】Objective： To observe the effect of arterial thrombolysis in patients with acute cerebral infarction. Methods： 87 patients with acute cerebral infarction admitted to our hospital from December 2021 to December 2022 were observed by random number method. 45 patients receiving arterial thrombolytic therapy were included in the study group， and 42 patients receiving intravenous thrombolytic therapy were included in the control group. The therapeutic effects were compared and observed. Results： Compared with the control group （73.81%）， the therapeutic effect of the study group （95.56%） was significantly better （P0.05）； Compared with the control group （10.55±1.35）， the NIHSS score of the research group was significantly better after treatment （10.55±1.35） （P0.05）； Compared with control group （154.55±11.23） pg/mL， （35.40±5.75） μg/L， （92.35±10.10） μg/L， The serum indexes （IL-6， TNF-α， CLU） were better （134.15±11.20） pg/mL， （24.02±5.55） μg/L， （81.12±10.25） μg/L in the study group after treatment （P

【Key Words】Arterial thrombolysis therapy； Acute cerebral infarction； Neurological impairment； Serum index

急性脑梗死在临床上作为一种发病率较高的疾病类型，致病原因为突发性脑动脉闭塞导致脑缺氧、梗死，以局限性脑组织血供异常造成神经功能损伤为病理表现[1]。（剩余3933字）